Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × INDUSTRY × Vaginal Atrophy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 156 Neoplasms 117 Prostatic Neoplasms 81 Lung Neoplasms 76 Colorectal Neoplasms 73 Leiomyoma 35 Pancreatic Neoplasms 33 Carcinoma, Hepatocellular 31 Lymphoma, Follicular 30 Neoplasm Metastasis 27 Carcinoma, Non-Small-Cell Lung 26 Skin Neoplasms 24 Liver Neoplasms 24 Colonic Neoplasms 24 Uterine Cervical Neoplasms 22 Multiple Myeloma 21 Head and Neck Neoplasms 21 Barrett Esophagus 21 Glioblastoma 20 Polycystic Ovary Syndrome 19 Brain Neoplasms 17 Urinary Bladder Neoplasms 16 Polyps 16 Carcinoma, Squamous Cell 14 Adenoma 14 Ovarian Neoplasms 13 Menorrhagia 13 Carcinoma, Basal Cell 13 Rectal Neoplasms 12 Gastrointestinal Neoplasms 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03998722 2020-11-13

Evaluation of VagiVital® for Treatment of Vaginal Atrophy

PepTonic Medical AB

Phase NA Completed

Vaginal Atrophy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡